Linda M. Richardson's most recent trade in Intercept Pharmaceuticals Inc was a trade of 386 Common Stock done at an average price of $21.2 . Disclosure was reported to the exchange on Feb. 14, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Intercept Pharmaceuticals Inc | Linda M. Richardson | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.21 per share. | 14 Feb 2023 | 386 | 43,291 (0%) | 0% | 21.2 | 8,187 | Common Stock |
Intercept Pharmaceuticals Inc | Linda M. Richardson | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 20,000 | 20,000 | - | - | Option to Purchase Common Stock | |
Intercept Pharmaceuticals Inc | Linda M. Richardson | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 12,200 | 43,677 (0%) | 0% | 0 | Common Stock | |
Intercept Pharmaceuticals Inc | Linda M. Richardson | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. | 31 Dec 2022 | 1,600 | 31,477 (0%) | 0% | 12.4 | 19,792 | Common Stock |
Intercept Pharmaceuticals Inc | Linda M. Richardson | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.06 per share. | 01 Sep 2022 | 597 | 33,077 (0%) | 0% | 18.1 | 10,782 | Common Stock |
Intercept Pharmaceuticals Inc | Linda M. Richardson | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.19 per share. | 15 Aug 2022 | 124 | 33,674 (0%) | 0% | 18.2 | 2,256 | Common Stock |
Intercept Pharmaceuticals Inc | Linda M. Richardson | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. | 15 May 2022 | 124 | 33,798 (0%) | 0% | 17.9 | 2,217 | Common Stock |
Intercept Pharmaceuticals Inc | Linda M. Richardson | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.93 per share. | 15 Feb 2022 | 171 | 33,922 (0%) | 0% | 15.9 | 2,724 | Common Stock |
Intercept Pharmaceuticals Inc | Linda M. Richardson | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.85 per share. | 14 Feb 2022 | 529 | 34,093 (0%) | 0% | 14.9 | 7,856 | Common Stock |
Intercept Pharmaceuticals Inc | Linda M. Richardson | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 17,600 | 17,600 | - | - | Option to Purchase Common Stock | |
Intercept Pharmaceuticals Inc | Linda M. Richardson | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 10,300 | 34,622 (0%) | 0% | 0 | Common Stock |